SCHEDULE: Jorey Chernett Exits CalciMedica Position

Jorey Chernett has filed an amendment to Schedule 13G confirming the complete divestment of all shares in CalciMedica, Inc.

Summary

• Jorey Chernett reported a total exit from their position in CalciMedica, Inc. (CALC).
• The filing serves as an exit statement, confirming that the reporting person no longer beneficially owns any shares of the issuer's common stock.
• The change in ownership status was effective as of May 19, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a routine disclosure of a shareholder exit that does not impact the company's operational or financial health.

Positives

• The filing provides clear transparency regarding the cessation of a significant shareholder's interest.

Negatives

• The departure of a shareholder may be perceived as a lack of long-term confidence in the issuer's immediate prospects.

Risks

• Potential market volatility if the market perceives the exit of a notable shareholder as a negative signal regarding the company's future performance.

Future Outlook

No forward-looking guidance provided as this is a notification of divestment.

Industry Context

StockSavvy.ai notes that Schedule 13G exit filings are standard regulatory disclosures and do not necessarily reflect fundamental changes in the issuer's business operations, but rather individual investment strategy shifts.

Comparison to Industry Standards

• This filing follows standard SEC regulatory requirements for reporting changes in beneficial ownership for individual investors.

Stakeholder Impact

• Minimal impact expected on general shareholders as this is an individual divestment.

Next Steps

• No further action required by the reporting person regarding this issuer.

Key Dates

Keywords

CalciMedica, CALC, Schedule 13G, Divestment, Shareholder Exit, SEC Filing